National Health Investors (NHI) AI Stock Analysis

• Market Cap: $3.54B
• Dividend Yield: 4.82%
• Average Volume (3M): 243.92K
• Price to Earnings (P/E): 23.8
• Beta (1Y): 0.39
• Revenue Growth: 6.87%
• EPS Growth: 7.23%
• Country: US
• Employees: 30
• Sector: Real Estate
• Sector Strength: 46
• Industry: REIT - Healthcare Facilities
• EPS (TTM): 0.79
• Shares Outstanding: 47,473,160
• 10 Day Avg. Volume: 250,414
• 30 Day Avg. Volume: 243,916
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: 1.24
• Enterprise Value/Revenue: 12.60
• Enterprise Value/Gross Profit: 14.34
• Enterprise Value/Ebitda: 16.09
• 1Y Price Target: $81.50
• Price Target Upside: 9.16% Upside
• Rating Consensus: Strong Buy
• Number of Analyst Covering: 6

• Rating: 77 Outperform
• Price Target: $85.00 ▲(13.85% Upside)

National Health Investors receives a strong score driven by solid financial performance and positive earnings call highlights, including increased guidance and dividend growth. Technical indicators suggest a positive trend, though caution is advised due to potential overbought conditions. The valuation is reasonable, and strategic corporate events further enhance growth prospects.

Positive Factors

Earnings

FAD earnings beat expectations highlighted by strong SHOP SSNOI growth.

Financial Performance

Norm-FFO per share beat consensus, indicating strong financial performance.

Negative Factors

Operational Challenges

Bickford's occupancy has also slipped, indicating potential operational challenges.

SHOP Performance

SHOP SSNOI growth was below expectations, impacted by seasonal occupancy declines.

National Health Investors Business Overview & Revenue Model

Company Description

Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.

How the Company Makes Money

National Health Investors generates revenue primarily through leasing its healthcare properties to operators, who pay rent based on long-term lease agreements. The company typically structures its leases to include fixed rent increases, ensuring a steady and predictable income stream. Additionally, NHI may earn income through mortgage financing and property management services. Key revenue streams include rental income from its diverse portfolio of properties, which consists of independent living, assisted living, and skilled nursing facilities. The company's strategic partnerships with experienced healthcare operators enhance its operational efficiency and tenant stability, contributing to its overall financial performance. NHI's focus on the growing demand for senior housing and healthcare services positions it well within a market with favorable long-term trends.

National Health Investors Financial Statement Overview

Summary

National Health Investors showcases a solid financial standing with consistent revenue and profit growth, strong profitability margins, and efficient cash flow management. The balance sheet is stable, though leverage is moderately high, which is typical in the REIT industry. The company is well-positioned for future growth, but must continue to manage its debt levels carefully to mitigate financial risk.

Income Statement

The company's gross profit margin remains strong, hovering around 96.7% in TTM, indicating efficient cost management. The net profit margin increased to approximately 41.2% in TTM, demonstrating improved profitability. Revenue growth has been consistent, with a TTM increase to $342.97 million from $335.18 million in the prior annual period. EBIT and EBITDA margins are also robust, reflecting healthy operational performance. However, the growth rate has slowed compared to earlier periods, suggesting potential saturation.

Balance Sheet

The debt-to-equity ratio is approximately 0.89 in TTM, indicating moderate leverage for a REIT. The return on equity improved to nearly 9.9% in TTM, showing effective utilization of shareholder funds. The equity ratio is stable at about 51.2%, reflecting a solid capital structure. While the debt level is significant, the company maintains a favorable equity position, balancing risk and potential returns.

Cash Flow

The company demonstrates a strong cash flow position with a consistent rise in free cash flow, up 2.8% in TTM. The operating cash flow to net income ratio is approximately 1.51, indicating efficient cash generation relative to net income. Free cash flow to net income ratio is robust at 1.48, underscoring the firm's capacity to generate cash above net earnings. Overall, cash flow management is a significant strength.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	349.38M	335.18M	319.83M	278.19M	298.71M	332.81M
Gross Profit	306.91M	324.02M	308.32M	268.41M	287.08M	323.16M
EBITDA	273.56M	264.16M	259.94M	151.99M	212.99M	303.95M
Net Income	142.93M	137.99M	135.65M	23.06M	62.19M	135.37M
Balance Sheet
Total Assets	2.70B	2.61B	2.49B	2.51B	2.84B	3.12B
Cash, Cash Equivalents and Short-Term Investments	18.64M	24.29M	22.35M	19.29M	37.41M	43.34M
Total Debt	0.00	1.15B	1.14B	1.15B	1.25B	1.51B
Total Liabilities	1.20B	1.23B	1.21B	1.22B	1.32B	1.60B
Stockholders Equity	1.48B	1.37B	1.25B	1.27B	1.51B	1.51B
Cash Flow
Free Cash Flow	209.95M	203.70M	180.71M	180.71M	210.79M	218.29M
Operating Cash Flow	212.50M	207.77M	184.45M	185.34M	210.86M	232.15M
Investing Cash Flow	-286.56M	-192.31M	-11.63M	197.94M	185.28M	-89.71M
Financing Cash Flow	76.48M	-13.57M	-169.72M	-401.25M	-402.99M	-111.76M

National Health Investors Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 74.66
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NHI, the sentiment is Positive. The current price of 74.66 is above the 20-day moving average (MA) of 72.46, above the 50-day MA of 71.30, and above the 200-day MA of 71.16, indicating a bullish trend. The MACD of 1.08 indicates Negative momentum. The RSI at 61.74 is Neutral, neither overbought nor oversold. The STOCH value of 67.80 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for NHI.

National Health Investors Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
CTRE	80 Outperform	$7.47B	28.28	8.36%	3.69%	50.84%	104.44%
NHI	77 Outperform	$3.54B	23.84	10.49%	4.82%	6.87%	7.23%
SBRA	74 Outperform	$4.43B	24.28	6.66%	6.50%	6.89%	240.70%
LTC	73 Outperform	$1.64B	19.47	8.94%	6.42%	8.18%	-16.83%
AHR	72 Outperform	$6.90B	―	-1.51%	2.47%	11.62%	―
Sector *	64 Neutral	C$2.01B	5.78	-0.88%	5.19%	1.82%	-17.96%
MPW	51 Neutral	$2.43B	―	-25.97%	7.90%	27.66%	18.03%

National Health Investors Corporate Events

National Health Investors Releases Q2 2025 Financial Insights

National Health Investors, Inc. has released its supplemental information for the quarter ended June 30, 2025. The report provides insights into the company’s financial performance, including adjusted segment NOI and real estate investments, highlighting the company’s focus on senior housing and medical facilities. The report also outlines various risks and uncertainties that could impact future performance, such as environmental laws, liability claims, and economic effects from international trade disputes.

The most recent analyst rating on (NHI) stock is a Buy with a $80.00 price target. To see the full list of analyst forecasts on National Health Investors stock, see the NHI Stock Forecast page.

National Health Investors Releases Investor Update Presentation

On August 6, 2025, National Health Investors, Inc. issued an investor update presentation available on their website. This update provides insights into the company’s operations and strategic positioning, highlighting potential impacts on stakeholders and the real estate investment trust industry.

The most recent analyst rating on (NHI) stock is a Buy with a $80.00 price target. To see the full list of analyst forecasts on National Health Investors stock, see the NHI Stock Forecast page.

National Health Investors Updates Investment Pipeline Strategy

On June 2, 2025, National Health Investors, Inc. issued an investor presentation updating its investment pipeline to approximately $331.4 million, with $126.7 million in signed letters of intent, including a $71 million investment in senior housing operating partnerships. This update reflects NHI’s strategic focus on expanding its investment portfolio, potentially impacting its market positioning and offering insights into future growth opportunities for stakeholders.

The most recent analyst rating on (NHI) stock is a Buy with a $80.00 price target. To see the full list of analyst forecasts on National Health Investors stock, see the NHI Stock Forecast page.

National Health Investors Holds 2025 Annual Meeting

On May 21, 2025, National Health Investors, Inc. held its 2025 Annual Meeting of Stockholders, where 80.26% of the company’s common stock was represented. During the meeting, four directors were elected, an amendment to declassify the board was approved, executive compensation was affirmed, and BDO USA, P.C. was ratified as the independent auditor for 2025.

The most recent analyst rating on (NHI) stock is a Buy with a $80.00 price target. To see the full list of analyst forecasts on National Health Investors stock, see the NHI Stock Forecast page.